H.C. Wainwright Reaffirms Buy on Balchem (BCPC), Lifts Price Target Following Strong Q2 Results

Balchem Corporation (NASDAQ:BCPC) ranks among the best mid-cap materials stocks to buy now. Following the company’s second-quarter financial reports, H.C. Wainwright maintained its Buy rating on Balchem Corporation (NASDAQ:BCPC) and increased its price target from $180 to $189 on August 5.

H.C. Wainwright Reaffirms Buy on Balchem (BCPC), Lifts Price Target Following Strong Q2 Results

For the second quarter of 2025, Balchem Corporation recorded revenue of $255.5 million, which was marginally higher than the $250.5 million reported in the first quarter and up 1% year-over-year. In contrast to H.C. Wainwright’s prediction of $1.09 per diluted share, the company’s GAAP net earnings came in at $1.17 per diluted share.

The Animal Health and Nutrition segment’s sales were about $56 million, somewhat lower than expected, while Specialty Products sales came in at $37.2 million, higher than expected. Meanwhile, the Industrial Products segment generated $1.48 million in revenue, which fell short of expectations.

Balchem Corporation manufactures, produces, and distributes specialty performance ingredients and materials for a range of markets, including industrial, pharmaceutical, animal health, animal nutrition, medical device sterilization, and nutritional.

READ NEXT: 10 Best Magic Formula Stocks for 2025 and 10 Best Retirement Stocks to Buy According to Hedge Funds.

This article is originally published at Insider Monkey.